Compare INM & AQB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INM | AQB |
|---|---|---|
| Founded | 1981 | 1991 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1M | 5.9M |
| IPO Year | 2020 | 2017 |
| Metric | INM | AQB |
|---|---|---|
| Price | $1.33 | $1.02 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 35.0K | ★ 68.5K |
| Earning Date | 11-05-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 62.68 | ★ 87.66 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,942,633.00 | $2,472,659.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $26.00 | $400.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 7.50 | N/A |
| 52 Week Low | $0.58 | $0.82 |
| 52 Week High | $2.33 | $7.80 |
| Indicator | INM | AQB |
|---|---|---|
| Relative Strength Index (RSI) | 49.58 | 46.51 |
| Support Level | $1.25 | $0.86 |
| Resistance Level | $1.44 | $1.02 |
| Average True Range (ATR) | 0.05 | 0.10 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 30.77 | 55.68 |
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.
AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.